Study title: Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial.
Type of medicine: Herbal and homoeopathic medicines | |||||
Therapeutic area: Surgical Procedures, Operative [E04] | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: Ethyl esters of iodized fatty acids of poppy seed oil | |||||
ATC code: V08AD01 | |||||
Document link: | |||||
Document date: | |||||
Study number: Lau-W-Y. Lancet, 06 MAR 1999, Vol/Iss/Pg. 353/9155 (797-801) | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |